# GELNIQUE 3%
> **NDA202513** · New Drug Application · Sponsor: ALLERGAN · Approved 2011-12-07
## Drug
- **FDA Application Number:** NDA202513
- **Application type:** New Drug Application
- **Brand name:** GELNIQUE 3%
- **Generic name:** Oxybutynin
- **Active ingredients:** OXYBUTYNIN
- **Dosage form:** GEL, METERED
- **Route:** TRANSDERMAL
- **Marketing status:** Discontinued
- **Sponsor:** ALLERGAN
- **First approval:** 2011-12-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202513)
---
*AI Analytics · CC0 1.0*